Back
Protara Therapeutics 10K Form
Buy
55
TARA
Protara Therapeutics
Last Price:
$5.37
Seasonality Move:
26.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TARA News And Ratings
See the #1 stock for the next 7 days that we like better than TARA
TARA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-8.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.96 |
| Price / Book: | 1.35 |
Profitability
| EPS (TTM): | -2.82000 |
|---|---|
| Net Income (TTM): | $-42M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Protara Therapeutics Earnings Forecast
Key Protara Therapeutics Financial Ratios
-
The Interest Expense is -1.72% of Operating Income.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Protara Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TARA |
| CUSIP: | 74365U |
| Website: | protaratx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TARA Technical Analysis vs Fundamental Analysis
Buy
55
Protara Therapeutics (TARA)
is a Buy
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a BuyThe current Protara Therapeutics [TARA] share price is $5.37. The Score for TARA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.